JAGUAR HEALTH, INC. Notes Payable
JAGUAR HEALTH, INC. (JAGX) had Notes Payable of $15.56 million as of 2026-06-30, per its 10-Q filed 2026-08-19.
Financial Statements › Balance Sheet › Liabilities
us-gaap:NotesPayable · last filed 2026-08-19
- 2026-06-30: Notes Payable $15.56M.
- 2026-03-31: Notes Payable $33.15M.
- 2025-12-31: Notes Payable $42.52M.
- 2025-09-30: Notes Payable $30.76M.
| Period end | Notes Payable | Notes Payable as first filed |
|---|---|---|
| 2026-06-30 | $15.56M 10-Q · filed 2026-08-19 | |
| 2026-03-31 | $33.15M 10-Q · filed 2026-05-20 | |
| 2025-12-31 | $42.52M 10-Q · filed 2026-08-19 | |
| 2025-09-30 | $30.76M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $29.31M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $37.06M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $35.54M 10-K · filed 2026-04-07 | |
| 2024-09-30 | $33.15M 10-Q · filed 2024-11-13 | |
| 2024-06-30 | $32.93M 10-Q · filed 2024-08-13 | |
| 2024-03-31 | $32.11M 10-Q · filed 2024-05-14 | |
| 2023-12-31 | $35.86M 10-K · filed 2025-03-31 | |
| 2023-09-30 | $34.67M 10-Q · filed 2023-11-14 | |
| 2022-12-31 | $33.63M 10-K · filed 2024-04-01 | |
| 2020-03-31 | $150.00K 10-Q · filed 2021-05-17 | |
| 2015-03-31 | $913.64K 10-Q · filed 2015-06-26 | |
| 2014-12-31 | $392.04K 10-K · filed 2016-03-29 | $478.71K 10-Q · filed 2015-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Latigo Biotherapeutics, Inc. (LTGO) | United States | $1.176B | |
| LB PHARMACEUTICALS INC (LBRX) | United States | $1.220B | -10.87 |
| OPKO HEALTH, INC. (OPK) | United States | $1.220B | -15.59 |
| Seaport Therapeutics, Inc. (SPTX) | United States | $1.131B | |
| HARROW, INC. (HROW) | United States | $1.240B | -42.77 |
| Damora Therapeutics, Inc. (DMRA) | $1.250B | -6.10 | |
| Amphastar Pharmaceuticals, Inc. (AMPH) | United States | $1.116B | 10.93 |
| Avalyn Pharma Inc. (AVLN) | United States | $1.267B | |
| First Tracks Biotherapeutics, Inc. (TRAX) | United States | $1.280B | |
| Alto Neuroscience, Inc. (ANRO) | United States | $1.065B | -11.02 |